Cargando…

Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients

BACKGROUND: Platinum-based drugs, including cisplatin and carboplatin, are the most active and extensively used agents for treating lung cancer. Genetic polymorphisms of DNA repair gene XPD and tumor suppressor gene TP53 are connected with alterations in enzyme activity. They may help explain interi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nairuz, Tahsin, Bushra, Most Umme, Kabir, Yearul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080366/ https://www.ncbi.nlm.nih.gov/pubmed/34967559 http://dx.doi.org/10.31557/APJCP.2021.22.12.3809

Ejemplares similares

TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients
por: Nairuz, Tahsin, et al.
Publicado: (2020)

Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
por: Wu, Wenting, et al.
Publicado: (2012)

Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Qiu, Mantang, et al.
Publicado: (2013)

Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
por: Mostaid, Md Shaki, et al.
Publicado: (2021)

Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male
por: Sonia, Jahanara Akter, et al.
Publicado: (2021)

Polymorphisms in XPD Gene Could Predict Clinical Outcome of Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer Patients: A Meta-Analysis of 24 Studies
por: Qin, Qin, et al.
Publicado: (2013)

XPD gene polymorphism and colorectal cancer risk
por: Kashfi, Seyed Mohammad Hossein, et al.
Publicado: (2013)

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
por: Chen, Juan, et al.
Publicado: (2014)

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

Crumbs and Xpd in mitosis
por: Yeom, Eunbyul, et al.
Publicado: (2015)

On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations
por: Cameroni, Elisabetta, et al.
Publicado: (2010)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

XPD–The Lynchpin of NER: Molecule, Gene, Polymorphisms, and Role in Colorectal Carcinogenesis
por: Sameer, Aga Syed, et al.
Publicado: (2018)

XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients
por: Guan, Qinghai, et al.
Publicado: (2017)

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
por: BRACHOVA, PAVLA, et al.
Publicado: (2014)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
por: Eiholzer, Ramona A., et al.
Publicado: (2020)

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis
por: Liu, Wenhui, et al.
Publicado: (2020)

XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk
por: Baccarelli, A, et al.
Publicado: (2004)

Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD
por: Chiang, Chun-Chi, et al.
Publicado: (2010)

The Effect of XPD Polymorphisms on Digestive Tract Cancers Risk: A Meta-Analysis
por: Du, Haina, et al.
Publicado: (2014)

XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
por: Zhou, Qiang, et al.
Publicado: (2021)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
por: Kupryjanczyk, Jolanta, et al.
Publicado: (2008)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses
por: Lin, Hung-Yu, et al.
Publicado: (2008)

Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
por: Bae, Eun Young, et al.
Publicado: (2011)

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells
por: Lorenzon, Ilaria, et al.
Publicado: (2019)

Effect of non-synonymous SNP on JAK1 protein structure and subsequent function
por: Liza, Rozario, et al.
Publicado: (2019)

XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample
por: Ji, Yong Bae, et al.
Publicado: (2010)

XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk
por: Long, Xi Dai, et al.
Publicado: (2009)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis
por: Wen, Min, et al.
Publicado: (2018)

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
por: Kim, Jin-Ah, et al.
Publicado: (2023)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients
por: Xue, Dan, et al.
Publicado: (2021)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.
por: Mavridou, D., et al.
Publicado: (1998)

TP53 rs1042522 polymorphism and early-onset breast cancer
por: Icen-Taskin, Irmak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_922p41u5m2fk1b44psnv1i5pn4